E Fund Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
13,789
+236
| +2% | +$3.49K | 0.01% | 360 |
|
|
2025
Q1 | $243K | Buy |
13,553
+1,072
| +9% | +$19.2K | 0.01% | 343 |
|
|
2024
Q4 | $217K | Buy |
+12,481
| New | +$217K | 0.01% | 353 |
|
|
2024
Q3 | – | Sell |
-11,071
| Closed | -$91K | – | 369 |
|
|
2024
Q2 | $91K | Sell |
11,071
-17,057
| -61% | -$140K | 0.01% | 306 |
|
|
2024
Q1 | $217K | Buy |
28,128
+5,218
| +23% | +$40.2K | 0.01% | 329 |
|
|
2023
Q4 | $206K | Buy |
22,910
+4,314
| +23% | +$38.8K | 0.01% | 278 |
|
|
2023
Q3 | $166K | Sell |
18,596
-8,198
| -31% | -$73.2K | 0.01% | 268 |
|
|
2023
Q2 | $412K | Buy |
26,794
+8,262
| +45% | +$127K | 0.03% | 160 |
|
|
2023
Q1 | $417K | Buy |
18,532
+1,781
| +11% | +$40.1K | 0.03% | 151 |
|
|
2022
Q4 | $352K | Buy |
16,751
+2,606
| +18% | +$54.8K | 0.03% | 206 |
|
|
2022
Q3 | $349K | Sell |
14,145
-809
| -5% | -$20K | 0.03% | 209 |
|
|
2022
Q2 | $362K | Buy |
14,954
+7,003
| +88% | +$170K | 0.03% | 204 |
|
|
2022
Q1 | $205K | Buy |
+7,951
| New | +$205K | 0.01% | 292 |
|